36.52 USD
-0.34 (-0.92%)
At close: Jan 30, 2026
36.52 USD
0 (0%)
After Hours: 1/30/2026, 4:30:02 PM
Overall HRMY gets a fundamental rating of 8 out of 10. We evaluated HRMY against 190 industry peers in the Pharmaceuticals industry. HRMY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. An interesting combination arises when we look at growth and value: HRMY is growing strongly while it also seems undervalued. With these ratings, HRMY could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year HRMY was profitable.
- In the past year HRMY had a positive cash flow from operations.
- HRMY had positive earnings in 4 of the past 5 years.
- Of the past 5 years HRMY 4 years had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 15.37%, HRMY belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 22.23%, HRMY belongs to the top of the industry, outperforming 92.63% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 17.20%, HRMY belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
- HRMY had an Average Return On Invested Capital over the past 3 years of 18.27%. This is significantly above the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.37% | ||
| ROE | 22.23% | ||
| ROIC | 17.2% |
ROA(3y)19.12%
ROA(5y)10.08%
ROE(3y)31.57%
ROE(5y)9.53%
ROIC(3y)18.27%
ROIC(5y)15.29%
1.3 Margins
- With an excellent Profit Margin value of 22.48%, HRMY belongs to the best of the industry, outperforming 91.58% of the companies in the same industry.
- HRMY's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 27.32%, HRMY belongs to the top of the industry, outperforming 93.16% of the companies in the same industry.
- HRMY's Operating Margin has declined in the last couple of years.
- The Gross Margin of HRMY (77.70%) is better than 83.16% of its industry peers.
- HRMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.32% | ||
| PM (TTM) | 22.48% | ||
| GM | 77.7% |
OM growth 3Y-2.32%
OM growth 5YN/A
PM growth 3Y21.57%
PM growth 5YN/A
GM growth 3Y-1.56%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- HRMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, HRMY has more shares outstanding
- The number of shares outstanding for HRMY has been reduced compared to 5 years ago.
- HRMY has a better debt/assets ratio than last year.
2.2 Solvency
- HRMY has an Altman-Z score of 5.49. This indicates that HRMY is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.49, HRMY is doing good in the industry, outperforming 75.26% of the companies in the same industry.
- The Debt to FCF ratio of HRMY is 0.57, which is an excellent value as it means it would take HRMY, only 0.57 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.57, HRMY belongs to the best of the industry, outperforming 96.84% of the companies in the same industry.
- A Debt/Equity ratio of 0.18 indicates that HRMY is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.18, HRMY perfoms like the industry average, outperforming 46.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 5.49 |
ROIC/WACC1.81
WACC9.53%
2.3 Liquidity
- A Current Ratio of 3.75 indicates that HRMY has no problem at all paying its short term obligations.
- HRMY has a Current ratio of 3.75. This is comparable to the rest of the industry: HRMY outperforms 57.89% of its industry peers.
- A Quick Ratio of 3.72 indicates that HRMY has no problem at all paying its short term obligations.
- With a Quick ratio value of 3.72, HRMY perfoms like the industry average, outperforming 58.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.75 | ||
| Quick Ratio | 3.72 |
3. Growth
3.1 Past
- HRMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.71%, which is quite impressive.
- The Earnings Per Share has been growing by 44.61% on average over the past years. This is a very strong growth
- The Revenue has grown by 21.13% in the past year. This is a very strong growth!
- The Revenue has been growing by 160.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)50.71%
EPS 3Y44.61%
EPS 5YN/A
EPS Q2Q%10.13%
Revenue 1Y (TTM)21.13%
Revenue growth 3Y32.77%
Revenue growth 5Y160.13%
Sales Q2Q%28.71%
3.2 Future
- HRMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.10% yearly.
- Based on estimates for the next years, HRMY will show a quite strong growth in Revenue. The Revenue will grow by 14.79% on average per year.
EPS Next Y30.39%
EPS Next 2Y29.73%
EPS Next 3Y25%
EPS Next 5Y35.1%
Revenue Next Year21.02%
Revenue Next 2Y18.62%
Revenue Next 3Y16.71%
Revenue Next 5Y14.79%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.48 indicates a reasonable valuation of HRMY.
- Compared to the rest of the industry, the Price/Earnings ratio of HRMY indicates a rather cheap valuation: HRMY is cheaper than 88.42% of the companies listed in the same industry.
- HRMY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.39.
- The Price/Forward Earnings ratio is 8.64, which indicates a very decent valuation of HRMY.
- Based on the Price/Forward Earnings ratio, HRMY is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
- HRMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.48 | ||
| Fwd PE | 8.64 |
4.2 Price Multiples
- 94.74% of the companies in the same industry are more expensive than HRMY, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, HRMY is valued cheaper than 95.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.09 | ||
| EV/EBITDA | 6.39 |
4.3 Compensation for Growth
- HRMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of HRMY may justify a higher PE ratio.
- A more expensive valuation may be justified as HRMY's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y29.73%
EPS Next 3Y25%
5. Dividend
5.1 Amount
- No dividends for HRMY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HARMONY BIOSCIENCES HOLDINGS / HRMY FAQ
Can you provide the ChartMill fundamental rating for HARMONY BIOSCIENCES HOLDINGS?
ChartMill assigns a fundamental rating of 8 / 10 to HRMY.
What is the valuation status of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
ChartMill assigns a valuation rating of 9 / 10 to HARMONY BIOSCIENCES HOLDINGS (HRMY). This can be considered as Undervalued.
Can you provide the profitability details for HARMONY BIOSCIENCES HOLDINGS?
HARMONY BIOSCIENCES HOLDINGS (HRMY) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
The Price/Earnings (PE) ratio for HARMONY BIOSCIENCES HOLDINGS (HRMY) is 11.48 and the Price/Book (PB) ratio is 2.52.
What is the earnings growth outlook for HARMONY BIOSCIENCES HOLDINGS?
The Earnings per Share (EPS) of HARMONY BIOSCIENCES HOLDINGS (HRMY) is expected to grow by 30.39% in the next year.